Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3116Neoplasms 2459Carcinoma, Non-Small-Cell Lung 1858Prostatic Neoplasms 1623Colorectal Neoplasms 1401Lung Neoplasms 1293Multiple Myeloma 930Neoplasm Metastasis 919Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 853Ovarian Neoplasms 800Melanoma 782Carcinoma, Hepatocellular 733Stomach Neoplasms 647Squamous Cell Carcinoma of Head and Neck 635Recurrence 635Brain Neoplasms 624Head and Neck Neoplasms 598Glioblastoma 558Lymphoma 549Uterine Cervical Neoplasms 535Triple Negative Breast Neoplasms 511Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Carcinoma, Renal Cell 501Hematologic Neoplasms 464Urinary Bladder Neoplasms 460Endometrial Neoplasms 457Colonic Neoplasms 445Sarcoma 433Lymphoma, Non-Hodgkin 432

Interventions

Speech Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Communication Disorders × 1 year × Clear all
NCT04969874 2026-05-12

E-CRIL_MAX

University Hospital, Toulouse

Phase NA Withdrawn

Communication Disorders

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated
13 enrolled 8 charts
CNS

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡